VALGANCICLOVIR, (S)-

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C14H22N6O5
Molecular Weight	354.3617
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

SMILES

CC(C)[C@H](N)C(=O)OC[C@H](CO)OCN1C=NC2=C1N=C(N)NC2=O

InChI

InChIKey=WPVFJKSGQUFQAP-IUCAKERBSA-N

InChI=1S/C14H22N6O5/c1-7(2)9(15)13(23)24-4-8(3-21)25-6-20-5-17-10-11(20)18-14(16)19-12(10)22/h5,7-9,21H,3-4,6,15H2,1-2H3,(H3,16,18,19,22)/t8-,9-/m0/s1

HIDE SMILES / InChI

Molecular Formula	C14H22N6O5
Molecular Weight	354.3617
Charge	0
Count	MOL RATIO 1 MOL RATIO (average)

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	2 / 2
E/Z Centers	0
Optical Activity	UNSPECIFIED

Originator

Approval Year

PubMed

Show entries

Title	Date	PubMed
Valganciclovir.	2001	11465875
Antiviral agents for influenza, hepatitis C and herpesvirus, enterovirus and rhinovirus infections.	2001 Jul 16	11556411
From the Food and Drug Administration.	2001 Jun 6	11386912
Cytomegalovirus infection: the point in 2001.	2001 Oct	11737406
New drugs for treating CMV. Valcyte, an oral compound, expands the treatment options for people with CMV retinitis.	2001 Oct-Nov	11702748